Inclusion criteria :
* Boys diagnosed during the first year of life
* Diagnosis of classical SCID-X1 based on immunophenotype (absent, or reduced numbers of non-functional T lymphocytes) and confirmed by DNA sequencing
* No HLA identical family donor and no HLA identical unrelated donor (10/10 antigens) found in the 6 weeks following the beginning of the search. This period could be shortened if the probability to find a donor is low or if the clinical situation (gravity) required
* Presence of a severe infection: pneumonitis and / or chronic diarrhea, or infection with herpes viruses or parainfluenza type 3 or adenovirus, or disseminated BCG infection, or presence of severe diarrhea and a severe compromise of the general state with denutrition
* Or failure of a HLA HAPLO-identical bone marrow transplant within 10 years after transplantation
* In all cases:
* No family background of cancer in childhood.
* No cytogenetic abnormalities (medullary karyotype) and no detection of main rearrangements associated with acute leukemia of children
* Parental/guardian voluntary consent
Exclusion criteria :
* Atypical health with autologous T\> 500/ml3
* Infection by HIV 1 or 2
* Allogeneic HSC completed (excluding situations of failure)
* Existence of an HLA identical family donor or HLA identical unrelated donor
* No severe infections in a child with a preserved general state
* Family background of cancer in childhood
* Detection of cytogenetic abnormality and / or rearrangement associated with acute leukemia of children
* No affiliation to a social security scheme (beneficiary or assignee)
View Inclusion and Exclusion Criteria at ClinicalTrials.gov